NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹1,751 Cr | ₹912 Cr | ₹264 Cr | ₹604 Cr | ₹583 Cr |
What is the latest Operating Profit of NATCO PHARMA ?
Year | Operating Profit |
---|---|
Mar2024 | ₹1,751 Cr |
Mar2023 | ₹912 Cr |
Mar2022 | ₹264 Cr |
Mar2021 | ₹604 Cr |
Mar2020 | ₹583 Cr |
How is Operating Profit of NATCO PHARMA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,751 Cr | 92.10 | |
Mar2023 | ₹912 Cr | 246.00 | |
Mar2022 | ₹264 Cr | -56.36 | |
Mar2021 | ₹604 Cr | 3.64 | |
Mar2020 | ₹583 Cr | - |
Compare Operating Profit of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹23,617.9 Cr | 13.5% | 6.7% | 54.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 13.5% |
6.7% |
54.6% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses